京新药业
(002020)
| 流通市值：81.81亿 | | | 总市值：97.30亿 |
| 流通股本：7.24亿 | | | 总股本：8.61亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,987,184,442.18 | 923,034,058.55 | 4,069,361,419.58 | 3,048,192,079.46 |
| 营业总成本 | 1,550,664,535.52 | 738,160,639.57 | 3,228,447,527.92 | 2,417,770,049.29 |
| 其他经营收益 | | | | |
| 营业利润 | 420,539,763.6 | 194,131,533.44 | 862,654,942.4 | 664,258,601.66 |
| 利润总额 | 412,531,646.86 | 191,374,366.42 | 864,325,602.05 | 664,916,102.75 |
| 净利润 | 355,950,434.85 | 166,150,235.51 | 766,667,967.92 | 581,417,539.53 |
| 每股收益 | | | | |
| 其他综合收益 | 282,436.32 | 209,371.89 | -91,596.05 | -121,128.61 |
| 综合收益总额 | 356,232,871.17 | 166,359,607.4 | 766,576,371.87 | 581,296,410.92 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 3,893,508,196.19 | 3,192,592,294.78 | 3,300,802,355.47 | 3,142,880,026.72 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,059,161,502.31 | 4,865,457,515.15 | 4,822,729,078.39 | 4,835,768,603.38 |
| 资产总计 | 7,952,669,698.5 | 8,058,049,809.93 | 8,123,531,433.86 | 7,978,648,630.1 |
| 流动负债: | | | | |
| 流动负债合计 | 1,568,864,575.44 | 1,572,078,247.03 | 1,906,909,059.03 | 1,939,835,860.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 345,431,101.75 | 353,900,688.43 | 346,354,873.09 | 353,293,153.53 |
| 负债合计 | 1,914,295,677.19 | 1,925,978,935.46 | 2,253,263,932.12 | 2,293,129,014.28 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,000,304,415.05 | 6,093,894,330.6 | 5,833,037,935.52 | 5,651,372,562.72 |
| 股东权益合计 | 6,038,374,021.31 | 6,132,070,874.47 | 5,870,267,501.74 | 5,685,519,615.82 |
| 负债和股东权益合计 | 7,952,669,698.5 | 8,058,049,809.93 | 8,123,531,433.86 | 7,978,648,630.1 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,034,436,535.87 | 982,794,705.18 | 3,946,293,309.77 | 2,990,689,343.98 |
| 经营活动现金流出小计 | 1,557,524,494.68 | 800,938,239.21 | 3,164,946,236.93 | 2,375,205,530.61 |
| 经营活动产生的现金流量净额 | 476,912,041.19 | 181,856,465.97 | 781,347,072.84 | 615,483,813.37 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,656,395,214.49 | 1,660,156,516.01 | 2,740,947,150.05 | 2,038,840,858.84 |
| 投资活动现金流出小计 | 2,807,374,029.02 | 1,955,847,474.72 | 2,373,841,173.93 | 1,524,375,046.19 |
| 投资活动产生的现金流量净额 | -150,978,814.53 | -295,690,958.71 | 367,105,976.12 | 514,465,812.65 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 258,444,018.42 | 89,042,500 | 567,346,679.45 | 373,136,048.92 |
| 筹资活动现金流出小计 | 603,261,690.29 | 86,744,654.88 | 1,483,095,603.54 | 1,354,514,420.77 |
| 筹资活动产生的现金流量净额 | -344,817,671.87 | 2,297,845.12 | -915,748,924.09 | -981,378,371.85 |
| 汇率变动对现金及现金等价物的影响 | -16,558,377.64 | -10,431,386.1 | -7,217,125.84 | -2,087,506.29 |
| 现金及现金等价物净增加额 | -35,442,822.85 | -121,968,033.72 | 225,486,999.03 | 146,483,747.88 |
| 期末现金及现金等价物余额 | 477,189,108.88 | 390,707,298.98 | 512,631,931.73 | 433,628,680.58 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -35,442,822.85 | - | 225,486,999.03 | - |
最新报告期：2026-09-05| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园 | 0.98 | 1.12 | 1.24 | 2026-09-05 |
| 平安证券 | 叶寅,曹艳凯,韩盟盟 | 0.92 | 1.03 | 1.12 | 2026-09-03 |
| 东方证券 | 伍云飞,胡俊涛 | 0.91 | 1.07 | 1.24 | 2026-08-30 |
| 东方证券 | 伍云飞,胡俊涛 | 0.94 | 1.08 | 1.26 | 2026-07-09 |